- Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway (vol 560, 216142, 2023)Zhang, Yuzhu; Chen, Jing; Mi, Dazhao; Ling, Jun; Li, Huachao; He, Peng; Liu, Ning; Chen, Qianjun*; Chen, Yihua*; Huang, Luqi*Cancer Letters, 2023, 567: 216195.
- Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasisYue, Cao; Wangjia, Cao; Yangmin, Qiu; Yuxin, Zhou; Qinglong, Guo; Yuan, Gao; Na, LuPharmacological Research, 2020, 159: 104981.被引 2
- Downregulated CDKN1C/p57(kiP2) drives tumorigenesis and associates with poor overall survival in breast cancerQiu Zhu; Li Yunhai; Zeng Beilei; Guan Xiaoqin; Li HongzhongBiochemical and Biophysical Research Communications, 2018, 497(1): 187-193.
期刊论文
Akt3 promotes cancer stemness in triple-negative breast cancer through YB1-Snail/Slug signaling axis
1被引13阅读
